Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kirsty McDowell

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Current Cardiovascular Imaging Reports|March 3, 2018
Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic ReviewKenneth Mangion, Kirsty McDowell, Patrick B Mark, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
European Journal of Heart Failure|November 8, 2023
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomesKirsty McDowell, Carly Adamson, Colette Jackson, et al.
European Journal of Heart Failure|May 16, 2023
Incremental prognostic value of biomarkers in PARADIGM-HFKirsty McDowell, Ross Campbell, Joanne Simpson, et al.
ESC Heart Failure|October 9, 2023
Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartanJawad H Butt, Kirsty McDowell, Toru Kondo, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA Cardiology|June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical TrialKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Journal of Cardiac Failure|March 7, 2025
Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection FractionElke Platz, Kirsty McDowell, Deepak K Gupta, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JAMA Cardiology|March 27, 2024
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection FractionKirsty McDowell, Toru Kondo, Atefeh Talebi, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Current Cardiovascular Imaging Reports|March 3, 2018
Characterizing Cardiac Involvement in Chronic Kidney Disease Using CMR-a Systematic ReviewKenneth Mangion, Kirsty McDowell, Patrick B Mark, et al.
JACC. Cardiooncology|November 16, 2023
Cardiotoxicity of BRAF/MEK Inhibitors: A Longitudinal Study Incorporating Contemporary Definitions and Risk ScoresClaire Glen, Sarah Adam, Kirsty McDowell, et al.
European Journal of Heart Failure|November 8, 2023
Neuropeptide Y is elevated in heart failure and is an independent predictor of outcomesKirsty McDowell, Carly Adamson, Colette Jackson, et al.
European Journal of Heart Failure|May 16, 2023
Incremental prognostic value of biomarkers in PARADIGM-HFKirsty McDowell, Ross Campbell, Joanne Simpson, et al.
ESC Heart Failure|October 9, 2023
Heart failure with preserved ejection fraction, red cell distribution width, and sacubitril/valsartanJawad H Butt, Kirsty McDowell, Toru Kondo, et al.
JAMA Cardiology|March 28, 2026
EMPEROR-Preserved Risk Model and Outcomes in the FINEARTS-HF Trial: A Prespecified Secondary Analysis of FINEARTS-HFMisato Chimura, Kirsty McDowell, Pardeep S Jhund, et al.
JAMA Cardiology|June 4, 2025
Cellular Adhesion Molecules and Adverse Outcomes in Chronic Heart Failure: Findings From the DAPA-HF Randomized Clinical TrialKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
Journal of Cardiac Failure|March 7, 2025
Pulmonary Congestion on Lung Ultrasound in Ambulatory Patients With Heart Failure With Preserved Ejection FractionElke Platz, Kirsty McDowell, Deepak K Gupta, et al.
European Journal of Heart Failure|January 22, 2022
Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HFKirsty McDowell, Paul Welsh, Kieran F Docherty, et al.
JAMA Cardiology|March 27, 2024
Prognostic Models for Mortality and Morbidity in Heart Failure With Preserved Ejection FractionKirsty McDowell, Toru Kondo, Atefeh Talebi, et al.
Pageof 2